BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 15476906)

  • 1. Effects of valdecoxib in the treatment of chronic low back pain: results of a randomized, placebo-controlled trial.
    Coats TL; Borenstein DG; Nangia NK; Brown MT
    Clin Ther; 2004 Aug; 26(8):1249-60. PubMed ID: 15476906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valdecoxib is associated with improved dyspepsia-related health compared with nonspecific NSAIDs in patients with osteoarthritis or rheumatoid arthritis.
    Rabeneck L; Goldstein JL; Vu A; Mayne TJ; Rublee DA
    Am J Gastroenterol; 2005 May; 100(5):1043-50. PubMed ID: 15842577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of valdecoxib in treating the signs and symptoms of severe rheumatoid arthritis: a 12-week, multicenter, randomized, double-blind, placebo-controlled study.
    Gibofsky A; Rodrigues J; Fiechtner J; Berger M; Pan S
    Clin Ther; 2007 Jun; 29(6):1071-85. PubMed ID: 17692722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery.
    Ott E; Nussmeier NA; Duke PC; Feneck RO; Alston RP; Snabes MC; Hubbard RC; Hsu PH; Saidman LJ; Mangano DT; ;
    J Thorac Cardiovasc Surg; 2003 Jun; 125(6):1481-92. PubMed ID: 12830070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction in opioid-related adverse events and improvement in function with parecoxib followed by valdecoxib treatment after non-cardiac surgery: a randomized, double-blind, placebo-controlled, parallel-group trial.
    Langford RM; Joshi GP; Gan TJ; Mattera MS; Chen WH; Revicki DA; Chen C; Zlateva G
    Clin Drug Investig; 2009; 29(9):577-90. PubMed ID: 19663520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective treatment of laparoscopic cholecystectomy pain with intravenous followed by oral COX-2 specific inhibitor.
    Joshi GP; Viscusi ER; Gan TJ; Minkowitz H; Cippolle M; Schuller R; Cheung RY; Fort JG
    Anesth Analg; 2004 Feb; 98(2):336-342. PubMed ID: 14742366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valdecoxib for treatment of primary dysmenorrhea. A randomized, double-blind comparison with placebo and naproxen.
    Daniels SE; Torri S; Desjardins PJ
    J Gen Intern Med; 2005 Jan; 20(1):62-7. PubMed ID: 15693930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of valdecoxib in treating the signs and symptoms of rheumatoid arthritis: a randomized, controlled comparison with placebo and naproxen.
    Bensen W; Weaver A; Espinoza L; Zhao WW; Riley W; Paperiello B; Recker DP
    Rheumatology (Oxford); 2002 Sep; 41(9):1008-16. PubMed ID: 12209034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valdecoxib is as effective as diclofenac in the management of rheumatoid arthritis with a lower incidence of gastroduodenal ulcers: results of a 26-week trial.
    Pavelka K; Recker DP; Verburg KM
    Rheumatology (Oxford); 2003 Oct; 42(10):1207-15. PubMed ID: 12810937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rofecoxib 50 mg and valdecoxib 20 or 40 mg in adults and adolescents with postoperative pain after third molar extraction: results of two randomized, double-blind, placebo-controlled, single-dose studies.
    Daniels SE; Desjardins PJ; Bird SR; Smugar SS; Tershakovec AM
    Clin Ther; 2006 Jul; 28(7):1022-34. PubMed ID: 16990080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valdecoxib for treatment of a single, acute, moderate to severe migraine headache.
    Kudrow D; Thomas HM; Ruoff G; Ishkanian G; Sands G; Le VH; Brown MT
    Headache; 2005 Oct; 45(9):1151-62. PubMed ID: 16178945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valdecoxib: a review of its use in the management of osteoarthritis, rheumatoid arthritis, dysmenorrhoea and acute pain.
    Fenton C; Keating GM; Wagstaff AJ
    Drugs; 2004; 64(11):1231-61. PubMed ID: 15161329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valdecoxib is as efficacious as diclofenac in the treatment of acute low back pain.
    Ximenes A; Robles M; Sands G; Vinueza R
    Clin J Pain; 2007; 23(3):244-50. PubMed ID: 17314584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of rofecoxib in patients with chronic low back pain: results from two 4-week, randomized, placebo-controlled, parallel-group, double-blind trials.
    Katz N; Ju WD; Krupa DA; Sperling RS; Bozalis Rodgers D; Gertz BJ; Gimbel J; Coleman S; Fisher C; Nabizadeh S; Borenstein D;
    Spine (Phila Pa 1976); 2003 May; 28(9):851-8; discussion 859. PubMed ID: 12941996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valdecoxib, a cyclooxygenase-2-specific inhibitor, is effective in treating primary dysmenorrhea.
    Daniels SE; Talwalker S; Torri S; Snabes MC; Recker DP; Verburg KM
    Obstet Gynecol; 2002 Aug; 100(2):350-8. PubMed ID: 12151162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of the COX-2 specific inhibitor valdecoxib in the management of osteoarthritis of the hip: a randomized, double-blind, placebo-controlled comparison with naproxen.
    Makarowski W; Zhao WW; Bevirt T; Recker DP
    Osteoarthritis Cartilage; 2002 Apr; 10(4):290-6. PubMed ID: 11950252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diazepam Is No Better Than Placebo When Added to Naproxen for Acute Low Back Pain.
    Friedman BW; Irizarry E; Solorzano C; Khankel N; Zapata J; Zias E; Gallagher EJ
    Ann Emerg Med; 2017 Aug; 70(2):169-176.e1. PubMed ID: 28187918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valdecoxib, a COX-2-specific inhibitor, is an efficacious, opioid-sparing analgesic in patients undergoing hip arthroplasty.
    Camu F; Beecher T; Recker DP; Verburg KM
    Am J Ther; 2002; 9(1):43-51. PubMed ID: 11782819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized placebo-controlled trial comparing efficacy and safety of valdecoxib with naproxen in patients with osteoarthritis.
    Kivitz A; Eisen G; Zhao WW; Bevirt T; Recker DP
    J Fam Pract; 2002 Jun; 51(6):530-7. PubMed ID: 12100776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presurgical intravenous parecoxib sodium and follow-up oral valdecoxib for pain management after laparoscopic cholecystectomy surgery reduces opioid requirements and opioid-related adverse effects.
    Gan TJ; Joshi GP; Zhao SZ; Hanna DB; Cheung RY; Chen C
    Acta Anaesthesiol Scand; 2004 Oct; 48(9):1194-207. PubMed ID: 15352969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.